Cargando…
Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030
BACKGROUND: Primaquine is effective against the latent liver stage of Plasmodium vivax. Eliminating the latent liver stage of P. vivax is one of the necessary conditions to achieve the goal of malaria elimination in Lao People’s Democratic Republic (PDR) by 2030. However, people with glucose-6-phosp...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416863/ https://www.ncbi.nlm.nih.gov/pubmed/30866940 http://dx.doi.org/10.1186/s12936-019-2715-0 |
_version_ | 1783403445413216256 |
---|---|
author | Ong, Ken Ing Cherng Iwagami, Moritoshi Araki, Hitomi Khattignavong, Phonepadith Soundala, Pheovaly Keomalaphet, Sengdeuane Prasayasith, Phoyphaylinh Lorpachan, Lavy Xangsayalath, Phonepadith Pongvongsa, Tiengkham Hongvanthong, Bouasy Brey, Paul T. Kano, Shigeyuki Jimba, Masamine |
author_facet | Ong, Ken Ing Cherng Iwagami, Moritoshi Araki, Hitomi Khattignavong, Phonepadith Soundala, Pheovaly Keomalaphet, Sengdeuane Prasayasith, Phoyphaylinh Lorpachan, Lavy Xangsayalath, Phonepadith Pongvongsa, Tiengkham Hongvanthong, Bouasy Brey, Paul T. Kano, Shigeyuki Jimba, Masamine |
author_sort | Ong, Ken Ing Cherng |
collection | PubMed |
description | BACKGROUND: Primaquine is effective against the latent liver stage of Plasmodium vivax. Eliminating the latent liver stage of P. vivax is one of the necessary conditions to achieve the goal of malaria elimination in Lao People’s Democratic Republic (PDR) by 2030. However, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at risk of haemolysis when ingesting primaquine. The aim of this study was to detect the prevalence of the G6PD Viangchan variant, which is said to be common in Lao PDR and which can result in severe haemolysis in patients exposed to primaquine. METHODS: Blood samples were collected from villagers in three malaria endemic provinces: Champasak and Savannakhet in the south, and Phongsaly in the north. Each blood sample was semi-quantitatively assayed for G6PD enzyme activity using the G6PD Assay Kit-WST Lyophilized (DOJINDO Laboratories, Japan). Blood samples that were found to be G6PD deficient were sequenced to detect G6PD Viangchan mutation. RESULTS: In total, 2043 blood samples were collected from Phongsaly (n = 426, 20.9%), Savannakhet (n = 924, 45.2%), and Champasak (n = 693, 33.9%) provinces in Lao PDR from 2016 to 2017. Of these, 964 (47.2%) were taken from male villagers and 1079 (52.8%) were taken from female villagers. G6PD Viangchan mutation was not detected in Phongsaly province in this study. In Savannakhet province, 48 of the 924 samples (45 males, 3 females) had the G6PD Viangchan mutation (n = 48, 5.2%). In Champasak province, 42 of the 693 samples (18 males, 24 females) had the G6PD Viangchan mutation (n = 42, 6.1%). CONCLUSIONS: G6PD Viangchan variant, which can cause severe haemolysis in the carrier when exposed to primaquine, was detected among 6.1% of the villagers in Champasak and 5.2% in Savannakhet but not in Phongsaly in this study. G6PD Viangchan variant might be common in the south of Laos but not so in the north. In the north, other G6PD deficiency variants might be more prevalent. However, in order not to overlook anyone and ensure a safe primaquine therapy for people living in malaria endemic areas in Lao PDR, G6PD testing is necessary. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-019-2715-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6416863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64168632019-03-25 Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030 Ong, Ken Ing Cherng Iwagami, Moritoshi Araki, Hitomi Khattignavong, Phonepadith Soundala, Pheovaly Keomalaphet, Sengdeuane Prasayasith, Phoyphaylinh Lorpachan, Lavy Xangsayalath, Phonepadith Pongvongsa, Tiengkham Hongvanthong, Bouasy Brey, Paul T. Kano, Shigeyuki Jimba, Masamine Malar J Research BACKGROUND: Primaquine is effective against the latent liver stage of Plasmodium vivax. Eliminating the latent liver stage of P. vivax is one of the necessary conditions to achieve the goal of malaria elimination in Lao People’s Democratic Republic (PDR) by 2030. However, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at risk of haemolysis when ingesting primaquine. The aim of this study was to detect the prevalence of the G6PD Viangchan variant, which is said to be common in Lao PDR and which can result in severe haemolysis in patients exposed to primaquine. METHODS: Blood samples were collected from villagers in three malaria endemic provinces: Champasak and Savannakhet in the south, and Phongsaly in the north. Each blood sample was semi-quantitatively assayed for G6PD enzyme activity using the G6PD Assay Kit-WST Lyophilized (DOJINDO Laboratories, Japan). Blood samples that were found to be G6PD deficient were sequenced to detect G6PD Viangchan mutation. RESULTS: In total, 2043 blood samples were collected from Phongsaly (n = 426, 20.9%), Savannakhet (n = 924, 45.2%), and Champasak (n = 693, 33.9%) provinces in Lao PDR from 2016 to 2017. Of these, 964 (47.2%) were taken from male villagers and 1079 (52.8%) were taken from female villagers. G6PD Viangchan mutation was not detected in Phongsaly province in this study. In Savannakhet province, 48 of the 924 samples (45 males, 3 females) had the G6PD Viangchan mutation (n = 48, 5.2%). In Champasak province, 42 of the 693 samples (18 males, 24 females) had the G6PD Viangchan mutation (n = 42, 6.1%). CONCLUSIONS: G6PD Viangchan variant, which can cause severe haemolysis in the carrier when exposed to primaquine, was detected among 6.1% of the villagers in Champasak and 5.2% in Savannakhet but not in Phongsaly in this study. G6PD Viangchan variant might be common in the south of Laos but not so in the north. In the north, other G6PD deficiency variants might be more prevalent. However, in order not to overlook anyone and ensure a safe primaquine therapy for people living in malaria endemic areas in Lao PDR, G6PD testing is necessary. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-019-2715-0) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-12 /pmc/articles/PMC6416863/ /pubmed/30866940 http://dx.doi.org/10.1186/s12936-019-2715-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ong, Ken Ing Cherng Iwagami, Moritoshi Araki, Hitomi Khattignavong, Phonepadith Soundala, Pheovaly Keomalaphet, Sengdeuane Prasayasith, Phoyphaylinh Lorpachan, Lavy Xangsayalath, Phonepadith Pongvongsa, Tiengkham Hongvanthong, Bouasy Brey, Paul T. Kano, Shigeyuki Jimba, Masamine Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030 |
title | Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030 |
title_full | Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030 |
title_fullStr | Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030 |
title_full_unstemmed | Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030 |
title_short | Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030 |
title_sort | prevalence of g6pd viangchan variant in malaria endemic areas in lao pdr: an implication for malaria elimination by 2030 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416863/ https://www.ncbi.nlm.nih.gov/pubmed/30866940 http://dx.doi.org/10.1186/s12936-019-2715-0 |
work_keys_str_mv | AT ongkeningcherng prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT iwagamimoritoshi prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT arakihitomi prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT khattignavongphonepadith prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT soundalapheovaly prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT keomalaphetsengdeuane prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT prasayasithphoyphaylinh prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT lorpachanlavy prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT xangsayalathphonepadith prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT pongvongsatiengkham prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT hongvanthongbouasy prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT breypault prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT kanoshigeyuki prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 AT jimbamasamine prevalenceofg6pdviangchanvariantinmalariaendemicareasinlaopdranimplicationformalariaeliminationby2030 |